Key result
Cardiac contractility modulation added to optimal medical therapy improves peak VO2 and quality of life in heart failure patients, particularly those with an ejection fraction between 25% and 45%.
Why the study?
Does cardiac contractility modulation improve exercise tolerance and quality of life in patients with heart failure and reduced ejection fraction?
Design
Review
Authors
Loading...
May support CCM consideration in select HFrEF; leaves open need for confirmatory RCTs on outcomes.
Does cardiac contractility modulation improve exercise tolerance and quality of life in patients with heart failure and reduced ejection fraction?
Cardiac contractility modulation is a promising device-based therapy that improves functional capacity and quality of life in heart failure patients with reduced ejection fraction, particularly those with LVEF 35-45%.
Borggrefe et al. (2018) conducted a review in Heart failure (HF). Cardiac contractility modulation (CCM) vs. Optimal medical therapy was evaluated. Cardiac contractility modulation added to optimal medical therapy improves peak VO2 and quality of life in heart failure patients, particularly those with an ejection fraction between 25% and 45%.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: